This competing continuation grant is the second and last request for renewal of CA70269, the original funding for an epidemiologic study of the natural history of human papillomavirus (HPV) infection and cervical neoplasia in a low-income female population in Sao Paulo, Brazil. In collaboration with Brazilian colleagues, three of the authors began the study in 1993 in an attempt to understand attributes of the natural history of HPV that could be instrumental in designing strategies for preventing cervical cancer. Considering the public health and economic importance of cervical cancer and the widespread interest in HPV vaccines and in using HPV in cancer screening there is a need for long-ranging multidisciplinary studies of the natural history of HPV. The study accrued 2529 female subjects through March 1997. Subjects have been followed up in scheduled returns every 4 months in the first year, and twice yearly thereafter for a total of 5 years. Participants undergo a questionnaire-based interview have a cervical specimen taken for Pap cytology and HPV testing, and a blood sample drawn for HPV antibody serology. Follow-up will have been completed at the time current funding for the cohort study finishes in August 2002. The study's original objectives (1996-99 funding period) were: (1) to study the prevalence and incidence of persistent HPV infection in asymptomatic women; (2) to verify the hypothesis that persistent HPV infection increases risk of cervical lesions; (3) to search for determinants of persistent cervical HPV infection; (4) to search for molecular variants of HPV that may lead to an increased risk of cervical lesions; (5) to verify the hypothesis that viral burden in the cervix may be correlated with persistent infections and with lesion risk; and (6) to study the antibody response to HPV as a predictor of persistent HPV infection and of lesion risk. In the last successful continuation (1999-02 funding period) these objectives were expanded to include: (7) the search for specific HLA haplotypes associated with HPV persistence and lesion severity, and (8) to test the hypothesis that p53 gene polymorphism may influence resistance against viral persistence and to lesion development. This competing continuation is to conduct in-depth statistical analyses of the database accrued during the study and to add a new objective: (9) to study the role of insulin growth factors in mediating risk of persistent HPV infection and cervical lesions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA070269-07A1
Application #
6579757
Study Section
Special Emphasis Panel (ZRG1-SNEM-5 (02))
Program Officer
Starks, Vaurice
Project Start
1996-09-11
Project End
2005-07-31
Budget Start
2003-08-01
Budget End
2005-07-31
Support Year
7
Fiscal Year
2003
Total Cost
$270,000
Indirect Cost
Name
Mcgill University
Department
Type
DUNS #
205667090
City
Montreal
State
PQ
Country
Canada
Zip Code
H3 0-G4
Sichero, Laura; El-Zein, Mariam; Nunes, Emily M et al. (2017) Cervical Infection with Cutaneous Beta and Mucosal Alpha Papillomaviruses. Cancer Epidemiol Biomarkers Prev 26:1312-1320
Tota, Joseph E; Ramanakumar, Agnihotram V; Villa, Luisa L et al. (2016) Cervical Infection With Vaccine-Associated Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections. J Infect Dis 214:676-84
Shaw, Eileen; Ramanakumar, Agnihotram V; El-Zein, Mariam et al. (2016) Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study. BMC Infect Dis 16:116
El-Zein, Mariam; Richardson, Lyndsay; Franco, Eduardo L (2016) Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none. J Clin Virol 76 Suppl 1:S62-S68
Trottier, Helen; Mayrand, Marie-Hélène; Baggio, Maria Luiza et al. (2015) Risk of Human Papillomavirus (HPV) Infection and Cervical Neoplasia after Pregnancy. BMC Pregnancy Childbirth 15:244
Tota, Joseph E; Ramanakumar, Agnihotram V; Villa, Luisa L et al. (2015) Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens. Cancer Epidemiol Biomarkers Prev 24:286-90
de Araujo-Souza, Patrícia S; Ramanakumar, Agnihotram V; Candeias, João M G et al. (2014) Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study. BMC Infect Dis 14:578
Tota, Joseph E; Ramanakumar, Agnihotram V; Jiang, Mengzhu et al. (2013) Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination. Am J Epidemiol 178:625-34
Trevisan, Andrea; Schlecht, Nicolas F; Ramanakumar, Agnihotram V et al. (2013) Human papillomavirus type 16 viral load measurement as a predictor of infection clearance. J Gen Virol 94:1850-7
Walter, Stephen D; Riddell, Corinne A; Rabachini, Tatiana et al. (2013) Accuracy of p53 codon 72 polymorphism status determined by multiple laboratory methods: a latent class model analysis. PLoS One 8:e56430

Showing the most recent 10 out of 50 publications